The DOI matches its Crossref record; 270 of the 270 references it cites were found in a registry or an index.
Current trends in drug metabolism and pharmacokinetics
Open accessAbstract
Pharmacokinetics (PK) is the study of the absorption, distribution, metabolism, and excretion (ADME) processes of a drug. Understanding PK properties is essential for drug development and precision medication. In this review we provided an overview of recent research on PK with focus on the following aspects: (1) an update on drug-metabolizing enzymes and transporters in the determination of PK, as well as advances in xenobiotic receptors and noncoding RNAs (ncRNAs) in the modulation of PK, providing new understanding of the transcriptional and posttranscriptional regulatory mechanisms that result in inter-individual variations in pharmacotherapy; (2) current status and trends in assessing drug-drug interactions, especially interactions between drugs and herbs, between drugs and therapeutic biologics, and microbiota-mediated interactions; (3) advances in understanding the effects of diseases on PK, particularly changes in metabolizing enzymes and transporters with disease progression; (4) trends in mathematical modeling including physiologically-based PK modeling and novel animal models such as CRISPR/Cas9-based animal models for DMPK studies; (5) emerging non-classical xenobiotic metabolic pathways and the involvement of novel metabolic enzymes, especially non-P450s. Existing challenges and perspectives on future directions are discussed, and may stimulate the development of new research models, technologies, and strategies towards the development of better drugs and improved clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Han, Z., & Shi, L. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.11.121 · Cited by 118
RetractedGut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671
ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
Gaj, T., Gersbach, C. A., & Barbas, C. F. (2013) · Trends in Biotechnology · doi:10.1016/j.tibtech.2013.04.004 · Cited by 3,820
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
Baert, F., Noman, M., Vermeire, S., Van Assche, G., D' Haens, G., Carbonez, A., & Rutgeerts, P. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020888 · Cited by 2,015
Revisiting the role of ABC transporters in multidrug-resistant cancer
Robey, R. W., Pluchino, K. M., Hall, M. D., Fojo, A. T., Bates, S. E., & Gottesman, M. M. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0005-8 · Cited by 1,866
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
Fleming, F. F., Yao, L., Ravikumar, P. C., Funk, L., & Shook, B. C. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100762r · Cited by 1,754
The Human ATP-Binding Cassette (ABC) Transporter Superfamily
Dean, M., Rzhetsky, A., & Allikmets, R. (2001) · Genome Research · doi:10.1101/gr.184901 · Cited by 1,748
The Human ATP-Binding Cassette (ABC) Transporter Superfamily
Dean, M. (2001) · Genome Research · doi:10.1101/gr.gr-1649r · Cited by 1,113
Roberts, J. A., Abdul-Aziz, M. H., Lipman, J., Mouton, J. W., Vinks, A. A., Felton, T. W., Hope, W. W., Farkas, A., Neely, M. N., Schentag, J. J., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70036-2 · Cited by 1,046
Nebert, D. W., & Dalton, T. P. (2006) · Nature Reviews Cancer · doi:10.1038/nrc2015 · Cited by 958
Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily
Marchitti, S. A., Brocker, C., Stagos, D., & Vasiliou, V. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.6.697 · Cited by 805
RNA regulation: A new genetics?
Mattick, J. S. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1321 · Cited by 765
Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century
Capecchi, M. R. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1619 · Cited by 684
Sepsis, severe sepsis and septic shock: changes in incidence, pathogens and outcomes
Martin, G. S. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.50 · Cited by 680
Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science
Rowland, M., Peck, C., & Tucker, G. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100540 · Cited by 662
Genovese, M. C., Cohen, S., Moreland, L., Lium, D., Robbins, S., Newmark, R., Bekker, P., & for the 20000223 Study Group (2004) · Arthritis & Rheumatism · doi:10.1002/art.20221 · Cited by 532
Fox, C. S., Golden, S. H., Anderson, C., Bray, G. A., Burke, L. E., de Boer, I. H., Deedwania, P., Eckel, R. H., Ershow, A. G., Fradkin, J., et al. (2015) · Diabetes Care · doi:10.2337/dci15-0012 · Cited by 492
The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients.
Ulldemolins, M., Roberts, J. A., Rello, J., Paterson, D. L., & Lipman, J. (2011) · Clinical Pharmacokinetics · doi:10.2165/11539220-000000000-00000 · Cited by 469
Zhu, H., Wu, H., Liu, X., Evans, B. R., Medina, D. J., Liu, C.-G., & Yang, J.-M. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.06.007 · Cited by 456
The Role of Transporters in the Pharmacokinetics of Orally Administered Drugs
Shugarts, S., & Benet, L. Z. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9924-0 · Cited by 438
Separating host and microbiome contributions to drug pharmacokinetics and toxicity
Zimmermann, M., Zimmermann-Kogadeeva, M., Wegmann, R., & Goodman, A. L. (2019) · Science · doi:10.1126/science.aat9931 · Cited by 423
MicroRNA Regulates the Expression of Human Cytochrome P450 1B1
Tsuchiya, Y., Nakajima, M., Takagi, S., Taniya, T., & Yokoi, T. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1403 · Cited by 408
ssODN-mediated knock-in with CRISPR-Cas for large genomic regions in zygotes
Yoshimi, K., Kunihiro, Y., Kaneko, T., Nagahora, H., Voigt, B., & Mashimo, T. (2016) · Nature Communications · doi:10.1038/ncomms10431 · Cited by 358
Watanabe, T., Kusuhara, H., Maeda, K., Shitara, Y., & Sugiyama, Y. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.146647 · Cited by 351
Current advances in humanized mouse models
Ito, R., Takahashi, T., Katano, I., & Ito, M. (2012) · Cellular & Molecular Immunology · doi:10.1038/cmi.2012.2 · Cited by 349
Local bacteria affect the efficacy of chemotherapeutic drugs
Lehouritis, P., Cummins, J., Stanton, M., Murphy, C. T., McCarthy, F. O., Reid, G., Urbaniak, C., Byrne, W. L., & Tangney, M. (2015) · Scientific Reports · doi:10.1038/srep14554 · Cited by 313
Progress and prospects in rat genetics: a community view
Aitman, T. J., Critser, J. K., Cuppen, E., Dominiczak, A., Fernandez-Suarez, X. M., Flint, J., Gauguier, D., Geurts, A. M., Gould, M., Harris, P. C., et al. (2008) · Nature Genetics · doi:10.1038/ng.147 · Cited by 291
Wagner, C., Zhao, P., Pan, Y., Hsu, V, Grillo, J., Huang, S., & Sinha, V (2015) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.33 · Cited by 276
MicroRNAs Regulate CYP3A4 Expression via Direct and Indirect Targeting
Pan, Y.-Z., Gao, W., & Yu, A.-M. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.027680 · Cited by 272
Self-citationSchmitt, C., Kuhn, B., Zhang, X., Kivitz, A. J., & Grange, S. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.35 · Cited by 257
Pharmacokinetics and toxicology of therapeutic proteins: Advances and challenges
Vugmeyster, Y. (2012) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v3.i4.73 · Cited by 242
The Emerging Role of Human Esterases
Fukami, T., & Yokoi, T. (2012) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-12-rv-042 · Cited by 239
CYP2A6: a human coumarin 7-hydroxylase
Pelkonen, O., Rautio, A., Raunio, H., & Pasanen, M. (2000) · Toxicology · doi:10.1016/s0300-483x(99)00200-0 · Cited by 236
NAD(P)H:Quinone Oxidoreductase 1 (NQO1) as a Therapeutic and Diagnostic Target in Cancer
Zhang, K., Chen, D., Ma, K., Wu, X., Hao, H., & Jiang, S. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00124 · Cited by 220
Ohtsuki, S., Asaba, H., Takanaga, H., Deguchi, T., Hosoya, K., Otagiri, M., & Terasaki, T. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01108.x · Cited by 219
THE SMALL INTESTINE AS A XENOBIOTIC-METABOLIZING ORGAN
Kaminsky, L. S., & Zhang, Q.-Y. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.12.1520 · Cited by 219
Knights, K. M., Rowland, A., & Miners, J. O. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12086 · Cited by 207
Applications of minimal physiologically-based pharmacokinetic models
Cao, Y., & Jusko, W. J. (2012) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-012-9280-2 · Cited by 202
Edginton, A. N., & Willmann, S. (2008) · Clinical Pharmacokinetics · doi:10.2165/00003088-200847110-00005 · Cited by 200
Tsai, H.-H., Lin, H.-W., Simon Pickard, A., Tsai, H.-Y., & Mahady, G. B. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2012.03008.x · Cited by 197
Lu, Y., Wu, D., Wang, X., Ward, S. C., & Cederbaum, A. I. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.07.026 · Cited by 192
Self-citationTsang, W. P., & Kwok, T. T. (2007) · Oncogene · doi:10.1038/sj.onc.1210266 · Cited by 188
MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells
Li, Z., Hu, S., Wang, J., Cai, J., Xiao, L., Yu, L., & Wang, Z. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.06.004 · Cited by 183
Updates on the Clinical Evidenced Herb‐Warfarin Interactions
Ge, B., Zhang, Z., & Zuo, Z. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/957362 · Cited by 180
Self-citationFeng, D., Zhang, H., Zhang, P., Zheng, Y., Zhang, X., Han, B., Luo, X., Xu, L., Zhou, H., Qu, L., et al. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01213.x · Cited by 175
Predicting Oral Drug Absorption: Mini Review on Physiologically-Based Pharmacokinetic Models
Lin, L., & Wong, H. (2017) · Pharmaceutics · doi:10.3390/pharmaceutics9040041 · Cited by 172
Herb-Drug Interactions and Mechanistic and Clinical Considerations
Chen, X.-W., B. Sneed, K., Pan, S.-Y., Cao, C., R. Kanwar, J., Chew, H., & Zhou, S. F. (2012) · Current Drug Metabolism · doi:10.2174/1389200211209050640 · Cited by 164
Self-citationRNA therapy: Are we using the right molecules?
Yu, A.-M., Jian, C., Yu, A. H., & Tu, M.-J. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.011 · Cited by 163
Self-citationTargeting xenobiotic receptors PXR and CAR for metabolic diseases
Gao, J., & Xie, W. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.07.003 · Cited by 159
Frye, R. F., Schneider, V. M., Frye, C. S., & Feldman, A. M. (2002) · Journal of Cardiac Failure · doi:10.1054/jcaf.2002.127773 · Cited by 159
PXR Ablation Alleviates Diet-Induced and Genetic Obesity and Insulin Resistance in Mice
He, J., Gao, J., Xu, M., Ren, S., Stefanović-Račić, M., O'Doherty, R. M., & Xie, W. (2013) · Diabetes · doi:10.2337/db12-1039 · Cited by 151
Pharmacology, Part 2: Introduction to Pharmacokinetics
Currie, G. M. (2018) · Journal of Nuclear Medicine Technology · doi:10.2967/jnmt.117.199638 · Cited by 149
Wagner, C., Pan, Y., Hsu, V., Grillo, J. A., Zhang, L., Reynolds, K. S., Sinha, V., & Zhao, P. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-014-0188-4 · Cited by 148
Wang, Y., Zhang, D., Wu, K., Zhao, Q., Nie, Y., & Fan, D. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01580-13 · Cited by 148
The biological and clinical role of drug transporters at the intestinal barrier
Oostendorp, R. L., Beijnen, J. H., & Schellens, J. H. M. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.09.004 · Cited by 142
N-glucuronidation of drugs and other xenobiotics by human and animal UDP-glucuronosyltransferases
Kaivosaari, S., Finel, M., & Koskinen, M. (2011) · Xenobiotica · doi:10.3109/00498254.2011.563327 · Cited by 140
Nguyen, T. V., Ukairo, O. T., Khetani, S. R., McVay, M., Kanchagar, C., Seghezzi, W., Ayanoglu, G., Irrechukwu, O., & Evers, R. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.061317 · Cited by 137
Role of CYP1A2 in Hepatic Sequestration of Dioxin: Studies Using CYP1A2 Knock-Out Mice
Diliberto, J. J., Burgin, D. E., & Birnbaum, L. S. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6973 · Cited by 134
Guo, Y., Chu, X., Parrott, N. J., Brouwer, K. L. R., Hsu, V., Nagar, S., Matsson, P., Sharma, P. K., Snoeys, J., Sugiyama, Y., et al. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1183 · Cited by 132
Yu, J., Zhou, Z., Tay-Sontheimer, J., Levy, R. H., & Ragueneau, I. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.04.004 · Cited by 129
Gut microbiota-mediated drug-antibiotic interactions
Kim, D.-H. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.063867 · Cited by 127
A generic whole body physiologically based pharmacokinetic model for therapeutic proteins in PK-Sim
Niederalt, C., Kuepfer, L., Solodenko, J., Eißing, T., Siegmund, H., Block, M. S., Willmann, S., & Lippert, J. (2017) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-017-9559-4 · Cited by 123
Characterization of hepatic cytochrome P4503A activity in patients with end‐stage renal disease
Dowling, T. C., Briglia, A., Fink, J. C., Hanes, D. S., Light, P. D., Stackiewicz, L., Karyekar, C. S., Eddington, N. D., Weir, M. R., & Henrich, W. L. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00056-0 · Cited by 122
He, J., Hu, B., Shi, X., Weidert, E. R., Lu, P., Xu, M., Huang, M., Kelley, E. E., & Xie, W. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01658-12 · Cited by 121
He, J., Lee, J. H., Febbraio, M., & Xie, W. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.011128 · Cited by 120
Foti, R., & Dalvie, D. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.071753 · Cited by 120
Schlender, J., Meyer, M. C., Thelen, K., Krauß, M., Willmann, S., Eißing, T., & Jaehde, U. (2016) · Clinical Pharmacokinetics · doi:10.1007/s40262-016-0422-3 · Cited by 119
Transcriptional regulation of human UDP-glucuronosyltransferase genes
Hu, D. G., Meech, R., McKinnon, R. A., & Mackenzie, P. I. (2014) · Drug Metabolism Reviews · doi:10.3109/03602532.2014.973037 · Cited by 118
A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer
Nakano, M., Fukami, T., Gotoh, S., & Nakajima, M. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.775684 · Cited by 118
The Role of the Gut Flora in the Metabolism of Prontosil and Neoprontosil in the Rat
Gingell, R., Bridges, J. W., & Williams, R. T. (1971) · Xenobiotica · doi:10.3109/00498257109044386 · Cited by 117
Bhattacharyya, S., Sinha, K., & Sil, P. C. (2014) · Current Drug Metabolism · doi:10.2174/1389200215666141125121659 · Cited by 116
Down‐regulation of hepatic cytochrome P450 in chronic renal failure: role of uremic mediators
Guévin, C., Michaud, J., Naud, J., Leblond, F. A., & Pichette, V. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704951 · Cited by 114
van Waterschoot, R. A. B., van Herwaarden, A. E., Lagas, J. S., Sparidans, R. W., Wagenaar, E., van der Kruijssen, C. M. M., Goldstein, J. A., Zeldin, D. C., Beijnen, J. H., & Schinkel, A. H. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.043869 · Cited by 114
Pharmacokinetics interactions of monoclonal antibodies
Ferri, N., Bellosta, S., Baldessin, L., Boccia, D., Racagni, G., & Corsini, A. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.07.015 · Cited by 114
Updated perspectives on the cytosolic sulfotransferases (SULTs) and SULT-mediated sulfation
Suiko, M., Kurogi, K., Hashiguchi, T., Sakakibara, Y., & Liu, M. (2016) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2016.1222266 · Cited by 110
Effect of excipients on breast cancer resistance protein substrate uptake activity
Yamagata, T., Kusuhara, H., Morishita, M., Takayama, K., Benameur, H., & Sugiyama, Y. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.08.021 · Cited by 108
The role of glucuronidation in drug resistance
Mazerska, Z., Mróz, A., Pawłowska, M., & Augustin, E. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.01.009 · Cited by 105
Jiang, Y., Feng, D., Ma, X., Fan, S., Gao, Y., Fu, K., Wang, Y., Sun, J., Yao, X., Liu, C., et al. (2019) · Hepatology · doi:10.1002/hep.30131 · Cited by 103
Self-citationMicrobiota–drug interactions: Impact on metabolism and efficacy of therapeutics
Wilkinson, E. M., Ilhan, Z. E., & Herbst‐Kralovetz, M. M. (2018) · Maturitas · doi:10.1016/j.maturitas.2018.03.012 · Cited by 101
Genetics, Epigenetics, and Regulation of Drug-Metabolizing Cytochrome P450 Enzymes
Zanger, U. M., Klein, K., Thomas, M., Rieger, J. K., Tremmel, R., Kandel, B. A., Klein, M. B., & Magdy, T. (2013) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2013.220 · Cited by 99
Seitz, K., & Zhou, G. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007306958 · Cited by 97
Role of organic anion transporter 1 (OAT1) in cephaloridine (CER)-induced nephrotoxicity
Takeda, M., Tojo, A., Sekine, T., Hosoyamada, M., Kanai, Y., & Endou, H. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00789.x · Cited by 97
Qiu, Z., Liu, M., Chen, Z., Shao, Y., Pan, H., Wei, G., Yu, C., Zhang, L., Li, X., Wang, P., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt258 · Cited by 95
Wagner, C., Pan, Y., Hsu, V., Sinha, V. P., & Zhao, P. (2015) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0330-y · Cited by 93
Activation of Pregnane X Receptor Disrupts Glucocorticoid and Mineralocorticoid Homeostasis
Zhai, Y., Pai, H. V., Zhou, J., Amico, J. A., Vollmer, R. R., & Xie, W. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0291 · Cited by 92
Tan, M., Yoshida, K. J., Zhao, P., Zhang, L., Nolin, T. D., Piquette‐Miller, M., Galetin, A., & Huang, S. M. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.807 · Cited by 92
Prediction of drug–drug interaction potential using physiologically based pharmacokinetic modeling
Min, J. S., & Bae, S. K. (2017) · Archives of Pharmacal Research · doi:10.1007/s12272-017-0976-0 · Cited by 92
FXR modulators for enterohepatic and metabolic diseases
Wang, H., He, Q., Wang, G., Xu, X., & Hao, H. (2018) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2018.1527906 · Cited by 92
Zhuang, Y., Xu, Z., Frederick, B., de Vries, D. E., Ford, J. A., Keen, M., Doyle, M. K., Petty, K. J., Davis, H. M., & Zhou, H. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.11.015 · Cited by 91
Nieto-Montesinos, R., Béduneau, A., Pellequer, Y., & Lamprecht, A. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.034 · Cited by 90
Hasegawa, M., Kapelyukh, Y., Tahara, H., Seibler, J., Rode, A., Krueger, S., Lee, D. N., Wolf, C. R., & Scheer, N. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.071845 · Cited by 89
Potentiating SLC transporter activity: Emerging drug discovery opportunities
Rives, M., Javitch, J. A., & Wickenden, A. D. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.02.010 · Cited by 88
UCA1 confers paclitaxel resistance to ovarian cancer through miR-129/ABCB1 axis
Wang, J., Ye, C., Liu, J., & Hu, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.05.104 · Cited by 88
Induction of cytochrome P450III and P450IV family proteins in streptozotocin-induced diabetes
Barnett, C. R., Gibson, G. G., Wolf, C. R., Flatt, P. R., & Ioannides, C. (1990) · Biochemical Journal · doi:10.1042/bj2680765 · Cited by 87
Hsu, V., Vieira, M. D. L. T., Zhao, P., Zhang, L., Zheng, J., Nordmark, A., Berglund, E. G., Giacomini, K. M., & Huang, S. M. (2013) · Clinical Pharmacokinetics · doi:10.1007/s40262-013-0117-y · Cited by 85
Underexpression of miR-224 in methotrexate resistant human colon cancer cells
Mencia-Trinchant, N., Selga, E., Noé, V., & Ciudad, C. J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.08.009 · Cited by 85
The endogenous substrates of brain CYP2D
Wang, X., Li, J., Dong, G., & Yue, J. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.12.025 · Cited by 82
Self-citationZhou, Y., Cao, S., Wang, Y., Xu, P., Yan, J., Bin, W., Qiu, F., & Kang, N. (2014) · Fitoterapia · doi:10.1016/j.fitote.2013.11.010 · Cited by 81
Chen, Q., Wang, W.-P., Zeng, S., Urayama, S., & Yu, A. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv228 · Cited by 81
Self-citationYu, A., Tian, Y., Tu, M., Ho, P. Y., & Jilek, J. L. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.067470 · Cited by 79
Self-citationEffect of quinidine on digoxin bioavailability
Pedersen, K. E., Christiansen, B. D., Klitgaard, N. A., & Nielsen‐Kudsk, F. (1983) · European Journal of Clinical Pharmacology · doi:10.1007/bf00613925 · Cited by 78
Transporter-Mediated Drug–Drug Interactions
Zhang, L., Sm, H., & Lesko, L. J. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.359 · Cited by 78
Rose, R., Neuhoff, S., Abduljalil, K., Chetty, M., Rostami‐Hodjegan, A., & Jamei, M. (2014) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2014.24 · Cited by 77
Zhang, K., Young, C., & Berger, J. E. (2006) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2006.12.8.640 · Cited by 77
Liu, H., Xu, X., Yang, Z., Deng, Y., Liu, X., & Xie, L. Y. (2006) · Brain Research · doi:10.1016/j.brainres.2006.09.061 · Cited by 76
Regulation of UDP-Glucuronosyltransferase 1A1 Expression and Activity by MicroRNA 491-3p
Dluzen, D. F., Sun, D., Salzberg, A. C., Jones, N. D., Bushey, R. T., Robertson, G. P., & Lazarus, P. J. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.210658 · Cited by 76
PXR Prevents Cholesterol Gallstone Disease by Regulating Biosynthesis and Transport of Bile Salts
He, J., Nishida, S., Xu, M., Makishima, M., & Xie, W. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.055 · Cited by 76
Yellepeddi, V., Rower, J. E., Liu, X., Kumar, S. S., Rashid, J., & Sherwin, C. M. T. (2018) · Clinical Pharmacokinetics · doi:10.1007/s40262-018-0677-y · Cited by 76
Xia, B., Heimbach, T., Gollen, R., Nanavati, C., & He, H. (2013) · The AAPS Journal · doi:10.1208/s12248-013-9505-3 · Cited by 74
Bioengineering of noncoding RNAs for research agents and therapeutics
Ho, P. Y., & Yu, A. (2016) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1324 · Cited by 73
Self-citationXu, Y. Y., Hijazi, Y., Wolf, A., Wu, B. M., Sun, Y., & Zhu, M. (2015) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12003 · Cited by 72
Kim, Y. C., Lee, A. K., Lee, J. H., Lee, I., Lee, D., Kim, S. H., Kim, S. G., & Lee, M. G. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.05.004 · Cited by 72
Yoshida, K. J., Sun, B., Zhang, L., et al. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.337 · Cited by 71
Li, X., Tian, Y. E., Tu, M., Ho, P. Y., Batra, N., & Yu, A. (2018) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2018.12.002 · Cited by 71
Self-citationIntestinal transporters: enhanced absorption through P-glycoprotein-related drug interactions
Zakeri‐Milani, P., & Valizadeh, H. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.905543 · Cited by 70
The reduction of sulphinpyrazone and sulindac by intestinal bacteria
Strong, H. A., RENWICK, A. G., George, C. F., Liu, Y. F., & Hill, M. J. (1987) · Xenobiotica · doi:10.3109/00498258709043976 · Cited by 70
Margolskee, A., Darwich, A. S., Pepin, X., Aarons, L., Galetin, A., Rostami-Hodjegan, A., Carlert, S., Hammarberg, M., Hilgendorf, C., Johansson, P., et al. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.10.036 · Cited by 69
The network of P-glycoprotein and microRNAs interactions
Lopes-Rodrigues, V., Seca, H., Sousa, D., Sousa, E., Lima, R. T., & Vasconcelos, M. H. (2013) · International Journal of Cancer · doi:10.1002/ijc.28500 · Cited by 69
Vuppugalla, R., Marathe, P., He, H., Jones, R. D. O., Yates, J. W. T., Jones, H. M., Gibson, C. R., Chien, J. Y., Ring, B. J., Adkison, K. K., et al. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22551 · Cited by 68
Wang, W., Ho, P. Y., Chen, Q., Addepalli, B., Limbach, P. A., Li, M., Wu, W., Jilek, J. L., Qiu, J., Zhang, H., et al. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.225631 · Cited by 67
Self-citationHarrison, L. I., & Gibaldi, M. (1977) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600661206 · Cited by 67
P-gp, MRP2 and OAT1/OAT3 mediate the drug-drug interaction between resveratrol and methotrexate
Jia, Y., Liu, Z., Wang, C., Meng, Q., Huo, X., Liu, Q., Sun, H., Sun, P., Yang, X., Ma, X., et al. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.06.030 · Cited by 67
Self-citationZhao, Y., Tu, M., Yu, Y.-F., Wang, W.-P., Chen, Q., Qiu, J.-X., Yu, A.-X., & Yu, A. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.10.015 · Cited by 66
Self-citationBioengineered Noncoding RNAs Selectively Change Cellular miRNome Profiles for Cancer Therapy
Ho, P. Y., Duan, Z., Batra, N., Jilek, J. L., Tu, M., Qiu, J.-X., Hu, Z., Wun, T., Lara, P. N., White, R. D., et al. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.247775 · Cited by 66
Self-citationYoshida, K. J., Budha, N. R., & Jin, J. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.622 · Cited by 65
Li, P., Tu, M., Ho, P. Y., Jilek, J. L., Duan, Z., Zhang, Q.-Y., Yu, A., & Yu, A. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.117.078741 · Cited by 63
Self-citationZeng, L., Chen, Y., Wang, Y., Yu, L., Knox, B., Chen, J., Shi, T., Chen, S., Ren, Z., Guo, L., et al. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.05.018 · Cited by 62
Self-citationZhang, H., Bu, F., Li, L., Jiao, Z., Ma, G., Cai, W., Zhuang, X., Lin, H., Shin, J., & Xiang, X. (2017) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12914 · Cited by 62
Xue, P., Liu, D., Wang, J., Zhang, N., Zhou, J., Li, L., Guo, W., Sun, M., Han, X., & Wang, Y. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00155 · Cited by 60
Self-citationMicroRNA hsa-miR-29a-3p modulates CYP2C19 in human liver cells
Yu, D., Green, B., Tolleson, W. H., Jin, Y., Mei, N., Guo, Y., Deng, H., Pogribny, I. P., & Ning, B. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.08.094 · Cited by 59
Jung, K. Y., Takeda, M., Shimoda, M., Narikawa, S., Tojo, A., Kim, D. K., Chairoungdua, A., Choi, B. K., Kusuhara, H., Sugiyama, Y., et al. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01500-x · Cited by 59
Li, M.-M., Addepalli, B., Tu, M., Chen, Q., Wang, W.-P., Limbach, P. A., LaSalle, J. M., Zeng, S., Huang, M., & Yu, A. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.064493 · Cited by 59
Self-citationZeng, H., Li, D., Qin, X., Chen, P., Tan, H., Zeng, X., Li, X., Fan, X., Jiang, Y., Zhou, Y., et al. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.066969 · Cited by 59
Self-citationMitochondrial regulation of macrophage cholesterol homeostasis
Graham, A. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.08.010 · Cited by 58
Yang, J., He, M. M., Niu, W., Wrighton, S. A., Li, L., Liu, Y., & Li, C. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.04076.x · Cited by 58
Plasma Pharmacokinetics of Antimicrobial Agents in Critically Ill Patients
Pea, F. (2013) · Current Clinical Pharmacology · doi:10.2174/157488413804810585 · Cited by 58
Scheer, N., Kapelyukh, Y., McEwan, J., Beuger, V., Stanley, L. A., Rode, A., & Wolf, C. R. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.075192 · Cited by 58
Preventing P-gp Ubiquitination Lowers Aβ Brain Levels in an Alzheimer’s Disease Mouse Model
Hartz, A. M. S., Zhong, Y., Shen, A. N., Abner, E. L., & Bauer, B. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00186 · Cited by 58
SULT2B1: unique properties and characteristics of a hydroxysteroid sulfotransferase family
Falany, C. N., & Rohn‐Glowacki, K. J. (2013) · Drug Metabolism Reviews · doi:10.3109/03602532.2013.835609 · Cited by 57
Pharmacokinetics of Chinese medicines: strategies and perspectives
Yan, R., Yang, Y. X., & Chen, Y. (2018) · Chinese Medicine · doi:10.1186/s13020-018-0183-z · Cited by 57
CAR Suppresses Hepatic Gluconeogenesis by Facilitating the Ubiquitination and Degradation of PGC1α
Gao, J., Yan, J., Xu, M., Ren, S., & Xie, W. (2015) · Molecular Endocrinology · doi:10.1210/me.2015-1145 · Cited by 56
Metabolism of levamisole, an anti-colon cancer drug, by human intestinal bacteria
Shu, Y. ‐., Kingston, D. G. I., Tassell, R. L. V., & Wilkins, T. D. (1991) · Xenobiotica · doi:10.3109/00498259109039513 · Cited by 56
Meng, J., Zhong, D., Li, L., Yuan, Z., Yuan, H., Xie, C., Zhou, J., Li, C., Gordeev, M. F., Liu, J., et al. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.061747 · Cited by 56
Self-citationAbduljalil, K., Jamei, M., & Johnson, T. N. (2018) · Clinical Pharmacokinetics · doi:10.1007/s40262-018-0685-y · Cited by 56
Scheer, N., Kapelyukh, Y., Chatham, L. R., Rode, A., Buechel, S., & Wolf, C. R. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.080036 · Cited by 55
Pan, Y., Hsu, V., Grimstein, M., Zhang, L., Arya, V., Sinha, V. P., Grillo, J. A., & Zhao, P. (2016) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.740 · Cited by 55
Yu, D., Wu, L., Gill, P. S., Tolleson, W. H., Chen, S., Sun, J., Knox, B., Jin, Y., Xiao, W., Hong, H., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2090-y · Cited by 55
Current knowledge of microRNA-mediated regulation of drug metabolism in humans
Nakano, M., & Nakajima, M. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1472237 · Cited by 55
Chen, L., Bao, Y., Piekos, S. C., Zhu, K., Zhang, L., & Zhong, X. (2018) · Molecular Pharmacology · doi:10.1124/mol.118.112235 · Cited by 55
Edeogu, C. O., Kalu, M. E., Famurewa, A. C., Asogwa, N. T., Onyeji, G. N., & Ikpemo, K. O. (2019) · Journal of the American College of Nutrition · doi:10.1080/07315724.2019.1649218 · Cited by 55
Nakano, M., Fukami, T., Gotoh, S., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.699363 · Cited by 54
Characterization of novel cytochrome P450 2E1 knockout rat model generated by CRISPR/Cas9
Wang, X., Tang, Y., Lu, J., Shao, Y., Qin, X., Li, Y., Wang, L., Li, D., & Liu, M. (2016) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.03.001 · Cited by 54
Self-citationTao, D., Wang, Y., Bao, X.-Q., Yang, B., Gao, F., Wang, L., Zhang, D., & Li, L. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.04.016 · Cited by 54
Activation of liver X receptor increases acetaminophen clearance and prevents its toxicity in mice
Saini, S. P. S., Zhang, B., Niu, Y., Jiang, M., Gao, J., Zhai, Y., Lee, J. H., Uppal, H., Tian, H., Tortorici, M. A., et al. (2010) · Hepatology · doi:10.1002/hep.24646 · Cited by 53
A Baeyer-Villiger Oxidation Specifically Catalyzed by Human Flavin-Containing Monooxygenase 5
Lai, W., Farah, N., Moniz, G. A., & Wong, Y. N. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.035360 · Cited by 53
Activation of the Liver X Receptor Prevents Lipopolysaccharide-induced Lung Injury
Gong, H., He, J., Lee, J. H., Mallick, E., Gao, X., Li, S., Homanics, G. E., & Xie, W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.047753 · Cited by 53
Lu, J., Shao, Y., Qin, X., Liu, D., Chen, A., Li, D., Liu, M., & Wang, X. (2017) · Scientific Reports · doi:10.1038/srep42922 · Cited by 53
Self-citationChen, P., Li, J., Fan, X., Zeng, H., Deng, R., Li, D., Huang, M., & Bi, H. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.08.029 · Cited by 52
Self-citationSun, Y., Wang, C., Meng, Q., et al. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26087 · Cited by 52
Self-citationTu, M., Ho, P. Y., Zhang, Q.-Y., Jian, C., Qiu, J.-X., Kim, E. J.-H., Bold, R. J., Gonzalez, F. J., Bi, H., & Yu, A. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.10.038 · Cited by 52
Self-citationRegulation of Human UGT2B15 and UGT2B17 by miR-376c in Prostate Cancer Cell Lines
Wijayakumara, D., Hu, D. G., Meech, R., McKinnon, R. A., & Mackenzie, P. I. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.226118 · Cited by 51
Siu, E. C. K., & Tyndale, R. F. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.133900 · Cited by 51
Chen, Y., Zeng, L., Wang, Y., Tolleson, W. H., Knox, B., Chen, S., Ren, Z., Guo, L., Mei, N., Qian, F., et al. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.08.012 · Cited by 51
Self-citationZhou, X., Zhao, Y., Wang, J., Wang, X., Chen, C., Yin, D., Zhao, F., Yin, J., Guo, M., Zhang, L., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.07.006 · Cited by 51
Self-citationDown-regulation of hepatic CYP1A2 plays an important role in inflammatory responses in sepsis
Crawford, J. H., Yang, S., Zhou, M., Simms, H. H., & Wang, P. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000109453.57709.e2 · Cited by 50
Löfgren, S., Baldwin, R. M., Hiratsuka, M., Lindqvist, A., Carlberg, A., Sim, S. C., Schuelke, M., Snait, M., Edenro, A., Fransson-Steen, R., et al. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.019349 · Cited by 50
Showande, S. J., Fakeye, T. O., Kajula, M., Hokkanen, J., & Tolonen, A. (2018) · Food Science & Nutrition · doi:10.1002/fsn3.789 · Cited by 50
Yu, Z., Tian, X., Peng, Y., Sun, Z., Wang, C., Tang, N., Ли, Б., Jian, Y., Wang, W., Huo, X., et al. (2018) · Journal of Pineal Research · doi:10.1111/jpi.12478 · Cited by 49
Kesisoglou, F., & Mitra, A. (2015) · The AAPS Journal · doi:10.1208/s12248-015-9781-1 · Cited by 48
Hu, N., Xie, S., Liu, L., Wang, X., Pan, X., Chen, G., Zhang, L., Liu, H., Liu, X., Liu, X., et al. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.035642 · Cited by 48
Self-citationGao, N., Tian, X., Fang, Y., Zhou, J., Zhang, H., Wen, Q., Jia, L.-J., Gao, J., Sun, B., Wei, J., et al. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.06.015 · Cited by 48
Lan, K., Xie, G., & Jia, W. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/819147 · Cited by 47
He, X., Shen, J., Ding, X., Lu, A. Y. H., & Hong, J. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.001370 · Cited by 47
Glutathione S-transferase alpha 4 induction by activator protein 1 in colorectal cancer
Yang, Y., Huycke, M. M., Herman, T. S., & Wang, X. (2016) · Oncogene · doi:10.1038/onc.2016.113 · Cited by 46
Self-citationEvaluation and Quantitative Prediction of Renal Transporter‐Mediated Drug‐Drug Interactions
Feng, B., & Varma, M. V. S. (2016) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.702 · Cited by 46
Zhang, X., Yin, J.-F., Zhang, J., Kong, S.-J., Zhang, H.-Y., & Chen, X.-M. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3344-3 · Cited by 46
Self-citationZhao, P. (2017) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12166 · Cited by 45
Jiang, X., Zhuang, Y., Xu, Z., Wang, W., & Zhou, H. (2016) · The AAPS Journal · doi:10.1208/s12248-016-9890-5 · Cited by 45
Sun, J., Wen, Y., Zhou, Y., Jiang, Y., Chen, Y., Zhang, H., Guan, L., Yao, X., Huang, M., & Bi, H. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0507-z · Cited by 44
Self-citationCao, Y., & Jusko, W. J. (2014) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-014-9374-0 · Cited by 44
Liu, L., & Liu, X. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00273 · Cited by 43
Aigrain, L., Pompon, D., & Truan, G. (2011) · Biochemical Journal · doi:10.1042/bj20101984 · Cited by 42
Huo, X., Liu, Q., Wang, C., Meng, Q., Sun, H., Peng, J., Ma, X., & Liu, K. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.08.010 · Cited by 42
Self-citationPhysiologically Based Pharmacokinetic Modeling of Therapeutic Proteins
Wong, H. H., & Chow, T. W. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.03.038 · Cited by 42
Kumar, R., Mota, L. C., Litoff, E. J., Rooney, J. P., Boswell, W. T., Courter, E., Henderson, C. M., Hernandez, J. P., Corton, J. C., Moore, D. D., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174355 · Cited by 41
A systematic evaluation of microRNAs in regulating human hepatic CYP2E1
Wang, Y., Yu, D., Tolleson, W. H., Yu, L., Green, B., Zeng, L., Chen, Y., Chen, S., Ren, Z., Guo, L., et al. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.04.020 · Cited by 41
Ono, C., Hsyu, P., Abbas, R., Loi, C., & Yamazaki, S. (2017) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.074450 · Cited by 40
Alnaqeeb, M., Mansoor, K., Mallah, E., Ghanim, B. Y., Idkaidek, N., & Qinna, N. A. (2019) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-019-2436-5 · Cited by 40
Peptides as Drugs: From Screening to Application
Dietrich, U., Duerr, R., & Koch, J. (2013) · Current Pharmaceutical Biotechnology · doi:10.2174/13892010113149990205 · Cited by 39
Shu, N., Hu, M., Ling, Z., Liu, P., Wang, F., Xu, P., Zhong, Z., Sun, B., Zhang, M., Li, F., et al. (2016) · Scientific Reports · doi:10.1038/srep33072 · Cited by 39
de Lange, E. C. M., Berg, D. J. V., Bellanti, F., Voskuyl, R. A., & Syvänen, S. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.08.022 · Cited by 39
Jilek, J. L., Zhang, Q.-Y., Tu, M., Ho, P. Y., Duan, Z., Qiu, J., & Yu, A. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.01.007 · Cited by 39
Self-citationZhang, H.-F., Li, Z.-H., Liu, J.-Y., Liu, T.-T., Wang, P., Fang, Y., Zhou, J., Cui, M.-Z., Gao, N., Tian, X., et al. (2016) · Drug Metabolism and Disposition · doi:10.1124/dmd.116.069849 · Cited by 38
Non-cytochrome P450-mediated bioactivation and its toxicological relevance
Gan, J., Ma, S., & Zhang, D. (2016) · Drug Metabolism Reviews · doi:10.1080/03602532.2016.1225756 · Cited by 38
Jorga, K. M., Chavanne, C., Frey, N., Lavé, T., Lukacova, V., Parrott, N. J., Peck, R., & Reigner, B. G. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.449 · Cited by 38
An update on efflux and uptake transporters as determinants of statin response
Rocha, K. C. E., Pereira, B. M. V., & Rodrigues, A. C. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1482276 · Cited by 38
Hu, N., Hu, M., Duan, R., Liu, C., Guo, H., Zhang, M., Yu, Y., Wang, X., Liu, L., & Liu, X. (2014) · Journal of Pharmacological Sciences · doi:10.1254/jphs.13212fp · Cited by 37
Self-citationLi, M.-M., Wang, W.-P., Wu, W.-J., Huang, M., & Yu, A. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.060145 · Cited by 37
Self-citationYiğitaslan, S., Erol, K., & Ünel, Ç. Ç. (2015) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/35254 · Cited by 37
Li, L., Carratt, S. A., Hartog, M. A., Kovalchuk, N., Jia, K., Wang, Y., Zhang, Q.-Y., Edwards, P., Winkle, L. S. V., & Ding, X. (2017) · Environmental Health Perspectives · doi:10.1289/ehp844 · Cited by 37
Cited by
Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design
Vora, L. K., Gholap, A. D., Jetha, K., Thakur, R. R. S., Solanki, H. K., & Chavda, V. P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071916 · Cited by 1,061
The Bioavailability of Drugs—The Current State of Knowledge
Stielow, M., Witczyńska, A., Kubryń, N., Fijałkowski, Ł., Nowaczyk, J., & Nowaczyk, A. (2023) · Molecules · doi:10.3390/molecules28248038 · Cited by 391
The Promise of Nanotechnology in Personalized Medicine
Alghamdi, M. A., Fallica, A. N., Virzì, N., Kesharwani, P., Pittalà, V., & Greish, K. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12050673 · Cited by 284
Therapeutic strategies to overcome taxane resistance in cancer
Das, T., Anand, U., Pandey, S. K., Ashby, C. R., Assaraf, Y. G., Chen, Z.-S., & Dey, A. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2021.100754 · Cited by 253
Biological sex differences in pharmacokinetics and adverse drug reactions
Aljohmani, A., & Yildiz, D. (2026) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-025-04721-8 · Cited by 35
Metadata
- Authors
- Li, Y., Meng, Q., Yang, M., Liu, D., Hou, X., Tang, L., Wang, X., Lyu, Y., Chen, X., Liu, K., Yu, A.-M., Zuo, Z., & Bi, H.
- Venue
- Acta Pharmaceutica Sinica B
- Publisher
- Elsevier BV
- Published
- 2019-11
- Volume
- 9
- Issue
- 6
- Pages
- 1113-1144
- ISSN
- 2211-3835 (ISSN-L)
- OpenAlex
- W2981132553
- Cited by
- 391
- References
- 270
- FWCI
- 19.76
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.